The US FDA completed a pre-license inspection of Biocon Biologics’ biosimilars manufacturing site at Biocon Park between April 20 and April 29, 2026
New Centre of Excellence at Electronic City campus to offer specialised care in epilepsy, cerebrovascular disorders, neurointervention, skull base and spine surgery
The newly established institute is equipped with advanced infrastructure designed to integrate multiple specialties under one roof
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
The new unit is expected to serve thousands of patients annually, helping address a critical gap in dialysis access
With the expansion, the hospital’s total bed capacity will rise from 380 to 539 beds
The campaign builds on the three-year partnership unveiled earlier this season
The initiative aligns with global psycho-oncology standards that advocate routine distress screening as a core quality benchmark in cancer treatment
New filtration lines will boost global drug supply and strengthen India’s role in Merck’s manufacturing network
Subscribe To Our Newsletter & Stay Updated
